Recent advances in the medicinal chemistry of aurones

Current Medicinal Chemistry

Volumn 19, Issue 18, 2012, Pages 2861-2875

  Haudecoeur, R ^a   Boumendjel, A ^a  

^a VERIMAG   (France)

Author keywords

Alzheimer's disease; Antioxidants; Antiviral; Aureusidin; Aurones; Cancer; Cytotoxicity; Flavonoids; Hepatitis C; Kinases; Sulfuretin; Tyrosinase

Indexed keywords

2' AMINOSULFONYL 4,6 HYDROXY 7(N METHYL)PIPERIDINYLAURONE; 2' CHLORO 4,6 HYDROXY 7 (N METHYL)PIPERIDINYLAURONE; 2' FLUORO 4,6 DIMETHOXYAURONE; 2',4',6' TRIHYDROXY 4 IODOCHALCONE; 2',6' DIHYDROXY 4' METHOXYCHALCONE; 3 CHLORO 2',4' DIMETHOXYCHALCONE; 3 HYDROXY 4,3',4',5' TETRAMETHOXYMETHYLCHALCONE; 3' CHLORO 4,6 DIMETHOXYAURONE; 3' FLUORO 4,6 DIMETHOXYAURONE; 3' HYDROXY 5,6,7,4' TETRAMETHOXYAURONE; 3' HYDROXY 6,7,8,4' TETRAMETHOXYFLAVONE; 4 HYDROXY 6 METHOXYAURONE; 4' BROMO 4,6 DIMETHOXYAURONE; 4' BROMO 5,7 DIHYDROXY 3 METHOXYFLAVONE; 5 ACETOXY 4' DIETHYLAMINOAURONE; 5 HYDROXY 4' DIETHYLAMINOAURONE; 6 ALLYLOXY 4' TRIFLUOROMETHYLAURONE; 7 ALLYLOXY 4' TRIFLUOROMETHYLFLAVONE; AURONE DERIVATIVE; BREAST CANCER RESISTANCE PROTEIN; CHALCONE DERIVATIVE; CYCLIN DEPENDENT KINASE; FLAVONE DERIVATIVE; FLAVONOID; FLAVOPIRIDOL; GLYCOPROTEIN P; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SPHINGOSINE KINASE; TECTOCHRYSIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOBESITY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPARASITIC ACTIVITY; ANTIVIRAL ACTIVITY; BINDING AFFINITY; CANCER CELL CULTURE; CANCER PREVENTION; CYTOTOXICITY; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 84861879624     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800672085     Document Type: Review

References (122)

1. Boumendjel. Aurones: A subclass of flavones with promising biological potential. Curr. Med. Chem., 2003, 10(23), 2621-2630.
2. Iwashina, T. The structure and distribution of the flavonoids in plants. J. Plant. Res., 2000, 113(3), 287-299.
3. Ono, E.; Fukuchi-Mizutani, M.; Nakamura, N.; Fukui, Y.; Yonekura- Sakakibara, K.; Yamaguchi, M.; Nakayama, T.; Tanaka, T.; Kusumi, T.; Tanaka, Y. Yellow flowers generated by expression of the aurone biosynthetic pathway. Proc. Natl. Acad. Sci. USA, 2006, 103(29), 11075-11080.
4. Gomez-Garibay, F.; Reyes-Chilpa, R.; Quijano, L.; Pardo, J.S.C.; Castillo, T.R. Methoxy furan auranols with fungistatic activity from Lonchocarpus castilloi. Phytochemistry, 1990, 29(2), 459-463.
5. Reyes-Chilpa, R.; Viveros-Rodriguez, N.; Gomez-Garibay, F.; Alavez- Solano, D. Antitermitic activity of Lonchocarpus castilloi flavonoids and heartwood extracts. J. Chem. Ecol., 1995, 21(4), 455-463.
6. Morimoto, M.; Fukumoto, H.; Nozoe, T.; Hagiwara, A.; Komai. K. Synthesis and insect antifeedant activity of aurones against Spodoptera litura larvae. J. Agric. Food. Chem., 2007, 55(3), 700-705.
7. Pare, P.W.; Dmitrieva, N.; Mabry, T.J. Phytoalexin aurone induced in Cephalocereus senilis liquid suspension culture. Phytochemistry, 1991, 30(4), 1133-1135.
8. Farag, M.A.; Deavours, B.E.; de Fatima, A.; Naoumkina, M.; Dixon, R.A.; Sumner, L.W. Integrated metabolite and transcript profiling identify a biosynthetic mechanism for hispidol in Medicago truncatula cell cultures. Plant Physiol., 2009, 151(3), 1096-1113.
9. Li, X.-C.; Cai, L.; Wu, C.D. Antimicrobial compounds from Ceanothus americanus against oral pathogens. Phytochemistry, 1997, 46(1), 97-102.
10. Li, W.; Asada, Y.; Yoshikawa, T. Flavonoid constituents from Glycyrrhiza glabra hairy root cultures. Phytochemistry, 2000, 55(5), 447-456.
11. Jankowski, K.; Paré, J.R.J. Trace glycoside from cranberries (Vaccinium oxycoccus). J. Nat. Prod., 1983, 46(2), 190-193.
12. Shomokoriyama, M.; Hattori, S. On a probable enzymatic conversion of hydroxychalcone glycoside into hydroxybenzyalcoumaranone glycoside. J. Am. Chem. Soc., 1953, 75(12), 2277-2281.
13. Nakayama, T.; Yonekura-Sakakibara, K.; Sato, T.; Kikuchi, S.; Fukui, Y.; Fukuchi-Mizutani, M.; Uead, T.; Nakao, M.; Tanaka, Y.; Kusumi, T.; Nishino, T. Aureusidin synthase: a polyphenol oxidase homolog responsible for flower coloration. Science, 2000, 290(5494), 1163-1166.
14. Sekizaki, H. Synthesis of 2-benzylidene-3(2H)-benzofuran-3-ones (aurones) by oxidation of 2'-hydroxychalcones with mercury(II) acetate. Bull. Chem. Soc. Jpn., 1988, 61(4), 1407-1409.
15. Thakkar, K. Cushman, M. A novel oxidative cyclization of 2'- hydroxychalcones to 4-methoxyaurones by thallium (III) nitrate. Tetrahedron Lett., 1994, 35(35), 6441-6444.
16. Thakkar, K., Cushman, M. A novel oxidative cyclization of 2'- hydroxychalcones to 4,5-dialkoxyaurones by thallium(III) nitrate. J. Org. Chem. 1995, 60(20), 6499-6510.
17. Bose, G.; Mondal, E.; Khan, A.T.; Bordoloi, M.J. An environmentally benign synthesis of aurones and flavones from 2'-acetoxychalcones using ntetrabutylammonium tribromide. Tetrahedron Lett., 2001, 42(50), 8907-8909.
18. Agrawal, N.N.; Soni, P.A. A new process for the synthesis of aurones by using mercury (II) acetate in pyridine and cupric bromide in dimethyl sulfoxide. Indian J. Chem., 2006, 45B(5), 1301-1303.
19. Harkat, H.; Blanc, A.; Weibel, J.-M.; Pale, P. Versatile and expeditious synthesis of aurones via AuI-catalyzed cyclization. J. Org. Chem., 2008, 73(4), 1620-1623.
20. Okombi, S.; Rival, D.; Bonnet, S.; Mariotte, A.-M.; Perrier, E.; Boumendjel, A. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes. J. Med. Chem., 2006, 49(1), 329-333.
21. Geissman, T.A.; Harborne, J.B. Anthochlor pigments. X. Aureusin and cernuoside. J. Am. Chem. Soc. 1955, 77(17), 4622-4624.
22. Varma, R.S.; Varma, M. Alumina-mediated condensation. A simple synthesis of aurones. Tetrahedron Lett., 1992, 33(40), 5937-5940.
23. Villemin, D.; Martin, B.; Bar, N. Application of microwave in organic synthesis. Dry synthesis of 2-arylmethylene-3(2)-naphthofuranones. Molecules, 1998, 3(3), 88-93.
24. Kraus, G.A. ; Gupta, V. Divergent approach to flavones and aurones via dihaloacrylic acids. Unexpected dependence on the halogen atom. Org. Lett., 2010, 12(22), 5278-5280.
25. Sheps, J.A.; Ling, V. Introduction: What is multidrug resistance?, in ABC transporters and multidrug resistance, A. Boumendjel, J. Boutonnat, J. Robert, Eds., Wiley, Hoboken, 2009, pp 1-13.
26. Juliano, R.L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 1976, 455(1), 152-162.
27. Cole, S.P.; Bhardwaj, G.; Gerlach, J.H.; Mackie, J.E; Grant, C.E.; Almquist, K.C.; Stewart, A.J.; Kurz, E.U.; Duncan, A.M.; Deeley, R.G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 1992, 258(5088), 1650-1654.
28. Doyle, L.A., Yang, W., Abruzzo, L.V.; Krogmann, T.; Gao, Y.; Rishi, A.K.; Ross, D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 1998, 95(26), 15665-15670.
29. Morris, M.E.; Zhang, S. Flavonoid-drug interactions: Effects of flavonoids on ABC transporters. Life Sci., 2006, 78(18), 2116-2130.
30. Boumendjel, A.; Beney, C.; Deka, N.; Mariotte, A.-M.; Lawson, M.A.; Trompier, D.; Baubichon-Coray, H.; Di Pietro, A. 4-Hydroxy-6- methoxyaurones with high-affinity binding to cytosolic domain of Pglycoprotein. Chem. Pharm. Bull., 2002, 50(6), 854-856.
31. Vaclavikova, R.; Boumendjel, A.; Ehrlichova, M.; Kovar, J.; Gut, I Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport? Bioorg. Med. Chem., 2006, 14(13), 4519-4525.
32. Sim, H.-M.; Lee, C.-Y.; Ee, P.L.R.; Go, M.-L. Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein). Eur. J. Pharm. Sci., 2008, 35(4), 293-306.
33. Sim, H.-M.; Wu, C.-P.; Ambudkar, S.V.; Go, M.-L. In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs. Biochem. Pharmacol., 2011, 82(11), 1562-1571.
34. Malumbres, M.; Barbacid , M. Cell cycle, CDKs and cancer: A changing paradigm. Nature Rev. Cancer, 2009, 9(3), 153-166.
35. Ni, W.; Ji, J;; Dai, Z.; Papp, A.; Johnson, A.J.; Ahn, S.; Farley, K.L.; Lin, T.S.; Dalton, J.T.; Li, X.; Jarjoura, D.; Byrd, J.C.; Sadee, W.; Grever, M.R.; Phelps, M.A. Flavopiridol pharmacogenetics: Clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. PLoS One, 2010, 5(11), e13792.
36. Schoepfer, J.; Fretz, H.; Chaudhuri, B.; Muller, L.; Seeber, E.; Meijer, L.; Lozach, O.; Vangrevelinghe, E.; Furet, P. Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics. J. Med. Chem., 2002, 45(9), 1741-1747.
37. Hait, N.C.; Oskeritzian, C.A.; Paugh, S.W.; Milstien, S.; Spiegel, S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta, 2006, 1758(12), 2016-2026.
38. French, K.J.; Schrecengost, R.S.; Lee, B.D.; Zhuang, Y.; Smith, S.N.; Eberly, J.L.; Yun, J.K.; Smith, C.D. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res., 2003, 63(18), 5962-5969.
39. L. Huang, M. E. Wall, M. C. Wani, H. Navarro, T. Santisuk, V. Reutreakul, E.-K. Seo, N. R. Farnsworth, A. D. Kinghorn. New compounds with DNA strand-scission activity from the combined leaf and stem of Uvaria hamiltonii. J. Nat. Prod. 1998, 61(4), 446-450.
40. Lawrence, N.J.; Rennison, D.; McGown, A.T.; Hadfield, J.A. The total synthesis of an aurone isolated from Uvaria hamiltonii: Aurones and flavones as anticancer agents. Bioorg. Med. Chem. Lett., 2003, 13(21), 3759-3763.
41. Zheng, X.; Cao, J.-G.; Meng, W.-D.; Qing, F.-L. Synthesis and anticancer effect of B-ring trifluoromethylated flavonoids. Bioorg. Med. Chem. Lett., 2003, 13(20), 3423-3427.
42. Huang, W.; Liu, M.-Z.; Li, Y.; Tan, Y.; G.-F. Yang, G.-F. Design, syntheses, and antitumor activity of novel chromone and aurone derivatives. Bioorg. Med. Chem., 2007, 15(15), 5191-5197.
43. Carmeliet, P. Angiogenesis in life, disease and medicine. Nature, 2005, 438(7070), 932-936.
44. Cheng, H.; Zheng, L.; Liu, Y.; Chen, S.; Cheng, H.; Lu, X.; Zheng, Z.; Zhou, G.-C. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines. Eur. J. Med. Chem., 2010, 45(12), 5950-5957.
45. Ross, D.; Kepa, J.K.; Winski, S.L.; Beall, H.D.; Anwar, A.; Siegel, D. NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms. Chem. Biol. Interact., 2000, 129(1-2), 77-97.
46. Cuendet, M.; Oteham, C.P.; Moon, R.C.; Pezzuto, J.M. Quinone reductase induction as a biomarker for cancer chemoprevention. J. Nat. Prod., 2006, 69(3), 460-463.
47. Nioi, P.; Hayes, J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helixloop- helix transcription factors. Mutation Res., 2004, 555(1-2), 149-171.
48. Jang, S.D.; Park, E.J.; Hawthorne, M.E.; Vigo, J.S.; Graham, J.G.; Cabieses, F.; Santarsiero, B.D.; Mesecar, A.D.; Fong, H.H.S.; Mehta, R.G.; Pezzuto, J.M.; Kinghorn, A.D. Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean). J. Nat. Prod., 2003, 66(5), 583-587.
49. Lee, C.-Y.; Chew, E.-H.; Go, M.-L. Functionalized aurones as inducers of NAD(P)H:quinine oxidoreductase 1 that activate AhR/XRE and Nrf2/ARE signaling pathways: Synthesis, evaluation and SAR. Eur. J. Med. Chem., 2010, 45(7), 2957-2971.
50. Yannai, S.; Day, A.J.; Williamson, G.; Rhodes, M.J.C. Characterization of flavonoids as monofunctional or bifunctional inducers of quinone reductase in murine hepatoma cell lines. Food Chem. Toxicol., 1998, 36(8), 623-630.
51. Dinkova-Kostova, A.T.; Massiah, M.A.; Bozak, R.E.; Hicks, R.J.; Talalay, P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl. Acad. Sci. USA., 2001, 98(6), 3404-3409.
52. Ahn, Y.H.; Hwang, Y.L; Liu, H.; Wang, X.J.; Zhang, Y.; Stephenson, K.K.; Boronina, T.N.; Cole, R.N.; Dinkova-Kostova, A.T.; Talalay, P.; Cole, P.A. Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc. Natl. Acad. Sci. USA., 2010, 107(21), 9590-9595.
53. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C.J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem., 2004, 266(1-2), 37-56.
54. Westenburg, H.E.; Lee, K.-J.; Lee, S.K.; Fong, H.H.S.; van Breemen, R.B.; Pezzuto, J.M.; Kinghorn, A.D. Activity-guided isolation of antioxidative constituents of Cotinus coggygria. J. Nat. Prod., 2000, 63(12), 1696-1698.
55. Demirci, B.; Demirci, F.; Baser, K.H.C. Composition of the essential oil of Cotinus coggygria Scop. From Turkey. Flavour Fragr. J., 2003, 18(1), 43-44.
56. Venkateswarlu, S.; Panchagnula, G.K.; Subbaraju, G.V. Synthesis and antioxidative activity of 3',4',6,7-tetrahydroxyaurone, a metabolite of Bidens frondosa. Biosci. Biotechnol. Biochem., 2004, 68(10), 2183-2185.
57. Furuno, K.; Akasako, T.; Sugihara, N. The contribution of the pyrogallol moiety to the superoxide radical scavenging activity of flavonoids. Biol. Pharm. Bull., 2002, 25(1), 19-23.
58. Zhang, H.-Y.; Yang, D.-P.; G.-Y. Tang, G.-Y. Multipotent antioxidants: From screening to design. Drug Discovery Today, 2006, 11(15-16), 749-754.
59. Nenadis, N. Sigalas, M.P. A DFT study on the radical scavenging activity of maritimetin and related aurones. J. Phys. Chem. A, 2008, 112(47), 12196-12202.
60. Sadasivam, K.; Kumaresan, R. A comparative DFT study on the antioxidant activity of apigenin and scutellarein flavonoid compounds. Mol. Phys. 2011, 109(6), 839-852.
61. Nenadis, N.; Sigalas, M.P. A DFT study on the radical scavenging potential of selected natural 3',4'-dihydroxy aurones. Food Res. Int., 2011, 44(1), 114-120.
62. Detsi, A.; Majdalani, M.; Kontogiorgis, C.A.; Hadjipavlou-Litina, D.; Kefalas, P. Natural and synthetic 2'-hydroxy-chalcones and aurones: Synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity. Bioorg. Med. Chem., 2009, 17(23), 8073-8085.
63. Riley, P.A. Melanin. Int. J. Biochem. Cell Biol., 1997, 29(11), 1235-1239.
64. Kim, Y.-J.; Uyama, H. Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future. Cell. Mol. Life Sci., 2005, 62(15), 1707-1723.
65. Peyroux, E.; Ghattas, W.; Hardré, R.; Giorgi, M.; Faure, B.; Simaan, A.J.; Belle, C.; Réglier, M. Binding of 2-hydroxypyridine-N-oxide on dicopper(II) centers: Insights into tyrosinase inhibition mechanism by transition-state analogs. Inorg. Chem., 2009, 48(23), 10874-10876.
66. Dubois, C.; Haudecoeur, R.; Orio, M.; Belle, C.; Bochot, C.; Boumendjel, A.; Hardré, R.; Jamet, J.; Réglier, M. Versatile effects of aurone structure on the mushroom tyrosinase activity. ChemBioChem, 2012, 13(4), 559-565.
67. Kayser, O.; Kiderlen, A.F. Leishmanicidal activity of aurones. Tokai J. Exp. Clin. Med. 1999, 23(6), 423-426.
68. Santhamma, K.R.; Bhaduri, A. Characterization of the respiratory chain of Leishmania donovani promastigotes. Mol. Biochem. Parasitol., 1995, 75(1), 43-53.
69. Kayser, O.; Chen, M.; Kharazmi, A. Kiderlen, A.F. Aurones interfere with Leishmania major mitochondrial fumarate reductase. Z. Naturforsch. 2002, 57(7-8), 717-720.
70. Saraiva, V.B.; Silva, L.S.; Ferreira-Da Silva, C.T.; Silva-Filho, J.L.; Teixeira-Ferreira, A.; Perales, J.; Souza, M.C.; Henriques, M.G.; Caruso- Neves, C.; Pinheiro, A.A.S. Impairment of the Plasmodium falciparum erythocytic cycle induced by angiotensin peptides. PLoS One, 2011, 6(2), e17174.
71. Kayser, O.; Kiderlen, A.F.; Brun, R. In vitro activity of aurones against Plasmodium falciparum strains K1 and NF54. Planta Med. 2001, 67(8), 718-721.
72. Saxena, S.; Pant, N.; Jain, D.C.; Bhakuni, R.S. Antimalarial agents from plant sources. Curr. Sci., 2003, 85(9), 1314-1329.
73. Tasdemir, S.; Lack, G.; Brun, R.; Rüedi, P.; Scapozza, L.; Perozzo, R. Inhibition of Plasmodium falciparum fatty acid biosynthesis: Evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J. Med. Chem., 2006, 49(11), 3345-3353.
74. Souard, F.; Okombi, S.; Beney, C.; Chevalley, S.; Valentin, A.; Boumendjel, A. 1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs. Bioorg. Med. Chem., 2010, 18(15), 5724-5731.
75. Bogaert, D.; van Belkum, A.; Sluijter, M.; Luijendijk, A.; de Groot, R.; Rümke, H.C.; Verbrugh, H.A.; Hermans, P.W.M. Colonisation by Streptococcus pneumonia and Staphylococcus aureus in healthy children. Lancet, 2004, 363(9424), 1871-1872.
76. Thomas, M.G.; Lawson, C.; Allanson, N.M.; Leslie, B.W.; Bottomley, J.R.; McBride, A.; Olusanya, O.A. A series of 2(Z)-2-benzylidene-6,7- dihydroxybenzofuran-3[2H]-ones as inhibitors of chorismate synthase. Bioorg. Med. Chem. Lett., 2003, 13(3), 423-426.
77. Pires, J.R.; Saito, C.; Gomes, S.L.; Giesbrecht, A.M.; Amaral, A.T. Investigation of 5-nitrofuran derivatives: Synthesis, antibacterial activity, and quantitative structure-activity relationships. J. Med. Chem., 2001, 44(22), 3673-3681.
78. Hadj-esfandiari, N.; Navidpour, L.; Shadnia, H.; Amini, M.; Samadi, N.; Faramarzi, A. Shafiee, M.A. Synthesis, antibacterial activity, and quantitative structure-activity relationships of new (Z)-2- (nitroimidazolylmethylene)-3(2H)- benzofuranone derivatives. Bioorg. Med. Chem. Lett., 2007, 17(22), 6354-6363.
79. Venkateswarlu, S.; Panchagnula, G.K.; Gottumukkala, A.L.; Subbaraju, G.V. Synthesis, structural revision, and biological activities of 4'-chloroaurone, a metabolite of marine brown alga Spatoglossum variabile. Tetrahedron, 2007, 63, 6909-6914.
80. Tiwari, K.N.; Monserrat, J.-P.; Hequet, A.; Ganem-Elbaz, C.; Cresteil, T.; Jaouen, G.; Vessières, A.; Hillard, E.A.; Jolivalt, C. In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures. Dalton Trans., 2012, in press (DOI: 10.1039/C2DT12180H).
81. Bhasker, N.; Reddy, M.K. Synthesis and characterization of new series of prenyloxy chalcones, prenyloxy aurones and screening for anti-bacterial activity. Int. J. Res. Pharm. Biomed. Sci., 2011, 2(3), 1266-1272.
82. Bandgar, B.P.; Patil, S.A.; Korbad, B.L.; Biradar, S.C.; Nile, S.N.; Khobragade, C.N. Synthesis and biological evaluation of a novel series of 2,2-bisaminomethylated aurone analogues as anti-inflammatory and antimicrobial agents. Eur. J. Med. Chem., 2010, 45(7), 3223-3227.
83. Chu, W.-L.A.; Jensen, F.R.; Jensen, T.B.; McAlpine, J.B.; Sokilde, B.; Santana-Sorensen, A.M.; Ratnayake, S.; Jiang, J.B.; Noble, C.; Stafford, A.M. Substituted aurone derivatives. Patent U.S. US 6307070, 2001.
84. Moscona, A. Neuraminidase inhibitors for influenza. New. Engl. J. Med., 2005, 353(25), 1363-1373.
85. Liu, A.-L.; Wang, H.-D.; Lee, S.M.; Wang, Y.-T.; Du, G.-H. Structureactivity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg. Med. Chem., 2008, 16(15), 7141-7147.
86. Mercader, A.G.; Pomilio, A.B. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. Eur. J. Med. Chem., 2010, 45(5), 1724-1730.
87. Grienke, U.; Schmidtke, M.; von Grafenstein, S.; Kirchmair, J.; Liedl, K.R.; Rollinger, J.M. Influenza neuraminidase: A druggable target for natural products. Nat. Prod. Rep., 2012, 29(1), 11-36.
88. Melnikova, I. Hepatitis C therapies. Nat. Rev. Drug. Discov., 2010, 10(2), 93-94.
89. Haudecoeur, R.; Ahmed-Belkacem, A.; Yi, W.; Fortuné, A.; Brillet, R.; Belle, C.; Nicolle, E.; Pallier, C.; Pawlotsky, J.-M.; Boumendjel, A. Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependant RNA polymerase. J. Med. Chem., 2011, 54(15), 5395-5402.
90. Sofia, M.J.; Chang, W.; Furman, P.A.; Mosley, R.T.; Ross, B.S. Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNAdependant RNA-polymerase. J. Med. Chem., 2012, in press (DOI: 10.1021/jm201384j).
91. Bianco, A.C.; Kim, B.W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest., 2006, 116(10), 2571-2579.
92. Maia, A.L.; Goemann, I.M.; Meyer, E.L.S.; Wajner, S.M. Type 1 iodothyronine deiodinase in human physiology and disease. J. Endocrinol., 2011, 209(3), 283-297.
93. Auf'mkolk, M.; Koehrle, J. ; Hesch, R.-D.; Cody, V. Inhibition of rat liver iodothyronine deiodinase. Interaction of aurones with the iodothyronine ligand-binding site. J. Biol. Chem., 1986, 261(25), 11623-11630.
94. Koehrle, J.; Auf'mkolk, M.; Rokos, H.; Hesch, R.-D.; Cody, V. Rat liver iodothyronine monodeiodinase. Evaluation of the iodothyronine ligandbinding site. J. Biol. Chem., 1986, 261(25), 11613-11622.
95. Deroo, B.J.; Korach, K.S. Estrogen receptors and human disease. J. Clin. Invest., 2006, 116(3), 561-570.
96. Köpcke, B.; Roemer, E.; Bitzer, J.; Hans, J.; Gruenwald, J.; Gehling, M.; Wabnitz, P.; Bin Tengku Adnan, T.S.; Grothe, T. Aurones as estrogen receptor modulators and their use in sex hormone dependent diseases. Patent U.S. US 0267822, 2010.
97. Wungsintaweekul, B.; Umehara, K.; Miyase, T.; Noguchi, H. Estrogenic and anti-estrogenic compounds from the Thai medicinal plant, Smilax corbularia (Smilacaceae). Phytochemistry, 2011, 72(6), 495-502.
98. Zhang, X.; Li, H.; Feng, H.; Xiong, H.; Zhang, L.; Song, Y.; Yu, L.; Deng, X. Valnemulin downregulates nitric oxide, prostaglandin E2, and cytokine production via inhibition of NF-κB and MAPK activity. Int. Immunopharmacol., 2009, 9(7-8), 810-816.
99. Hanada, T.; Yoshimura, A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev., 2002, 13(4-5), 413-421.
100. Sethi, G.; Sung, B.; Aggarwal, B.B. TNF: A master switch for inflammation to cancer. Front. Biosci., 2008, 13, 5094-5107.
101. Naugler, W.E.; Karin, M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol. Med., 2008, 14(3), 109-119.
102. Shin, J.-S.; Park, Y.M.; Choi, J.-H.; Park, H.-J.; Shin, M.C.; Lee, Y.S.; Lee, K.-T. Sulfuretin isolated from heartwood of Rhus verniciflua inhibits LPSinduced inducible nitric oxide synthase, cyclooxygenase-2, and proinflammatory cytokines expression via the down-regulation of NF-κB in RAW 264.7 murine macrophage cells. Int. Immunopharmacol., 2010, 10(8), 943-950.
103. Shin, S.Y.; Shin, M.C.; Shin, J.-S.; Lee, K.-T.; Lee, Y.S. Synthesis of aurones and their inhibitory effects on nitric oxide and PGE2 productions in LPS-induced RAW 264.7 cells. Bioorg. Med. Chem. Lett., 2011, 21(15), 4520-4523.
104. Nordberg, A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol., 2004, 3(9), 519-527.
105. Ono, M.; Yoshida, N.; Ishibashi, K.; Haratake, M.; Arano, Y.; Mori, H.; Nakayama, M. Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain. J. Med. Chem., 2005, 48(23), 7253-7260.
106. Ono, M.; Maya, Y.; Haratake, M.; Ito, K.; Mori, H.; Nakayama, M. Aurones serve as probes of beta-amyloid plaques in Alzheimer's disease. Biochem. Biophys. Res. Comm., 2007, 361(1), 116-121.
107. Maya, Y.; Ono, M.; Watanabe, H. Haratake, M.; Saji, H.; Nakayama, M. Novel radioiodinated aurones as probes for SPECT imaging of beta-amyloid plaques in the brain. Bioconjugate Chem., 2009, 20(1), 95-101.
108. Ono, M.; Ikeoka, R.; Watanabe, H.; Kimura, H.; Fuchigami, T.; Haratake, M.; Saji, H.; Nakayama, M. 99mTc/Re complexes based on flavone and aurone as SPECT probes for imaging cerebral ?-amyloid plaques. Bioorg. Med. Chem. Lett., 2010, 20(19), 5743-5748.
109. Lahiri, D.K.; Farlow, M.R.; Greig, N.H.; Sambamurti, K. Current drug targets for Alzheimer's disease treatment. Drug Dev. Res., 2002, 56, 267-281.
110. Sheng, R.; Xu, Y.; Hu, C.; Zhang, J.; Lin, X.; Li, J.; Yang, B.; He, Q.; Hu, Y. Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives. Eur. J. Med. Chem., 2009, 44(1), 7-17.
111. Nadri, H.; Pirali-Hamedani, M.; Shekarchi, M.; Abdollahi, M.; Sheibani, V.; Amanlou, M.; Shafiee, A.; Foroumadi, A. Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3- oxobenzofuran-2(3H)-ylidene)methyl) pyridinium derivatives. Bioorg. Med. Chem., 2008, 18(17), 6360-6366.
112. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature, 2001, 414(6865), 813-820.
113. Lee, E.H.; Song, D.-G.; Lee, J.Y.; Pan, C.-H.; Um, B.H.; Jung, S.H. Inhibitory effect of the compounds isolated from Rhus verniciflua on aldose reductase and advanced glycation endproducts. Biol. Pharm. Bull., 2008, 31(8), 1626-1630.
114. Song, M.-Y.; Jeong, G.-S.; Kwon, K.-B.; Ka, S.-O.; Jang, H.-Y.; Park, J.-W.; Kim, Y.-C.; Park, B.-H. Sulfuretin protects against cytokine-induced β-cell damage and prevents streptozotocin-induced diabetes. Exp. Mol. Med., 2010, 42(9), 628-638.
115. Bnouham, M.; Ziyyat, A.; Mekhfi, H.; Tahri, A.; Legssyer, A. Medicinal plants with potential antidiabetic activity - A review of ten years of herbal medicine research. (1990-2000). Int. J. Diabetes & Metabolism, 2006, 14, 1-25.
116. Mohan, P.; Joshi, T. Two aurone glycosides from the flowers of Pterocarpus marsupium. Phytochemistry, 1989, 28(4), 1287-1288.
117. Mohan, P.; Joshi, T. Two anhochlor pigments from heartwood of Pterocarpus marsupium. Phytochemistry, 1989, 28(9), 2529-2530.
118. Gurevich-Panigrahi, T.; Panigrahi, S.; Wiechec, E.; Los, M. Obesity: Pathophysiology and clinical management. Curr. Med. Chem., 2009, 16, 506-521.
119. Zhao, W.; Sun, J.; Xiang, H.; Zeng, Y.-Y.; Li, X.-B.; Xiao, H.; Chen, D.-Y.; Ma, R.-L. Synthesis and biological evaluation of new flavonoid fatty acid esters with anti-adipogenic and enhancing glucose consumption activities. Bioorg. Med. Chem., 2011, 19(10), 3192-3203.
120. Moro, C.O.; Basile, G. Obesity and medicinal plants. Fitoterapia, 2000, 71(Suppl 1), S73-S82.
121. Sadasivam, K.; Kumaresan, R. Antioxidant behavior of mearnsetin and myricetin flavonoid compounds - A DFT study. Spectrochimica Acta Part A, 2011, 79(1), 282-293.
122. Yahiaoui, S.; Peuchmaur, M.; Boumendjel, A. A straightforward conversion of aurones to 2-benzoylbenzofuranes: transformation of one class of natural products into another. Tetrahedron, 2011, 67(40), 7703-7707.